Formulation Optimization of Fenofibrate Nanomatrix System by Response Surface Methodology based on Central Composite Design and In Vivo Bioavailability Evaluation

Su-na He,Jie Li,Li-hong Li,Leng-xin Duan,Shu-ying Wang,Yan Li
2017-01-01
Latin american journal of pharmacy
Abstract:In order to improve the oral bioavailability of fenofibrate (FNB), the nanomatrix system was prepared. The nano-carrier and stabilizer were selected as Sylysia (S350) and Eudragit L100-55 (EL100-55), respectively. The formulation was optimized by the response surface methodology based on central composite design (RSM-CCD), S350: FNB and EL100-55: FNB as the two variables, the dissolution as the response value. The optimum formulation was as follow: S350: EL100-55: FNB = 3.19:2.44:1. Compared to Lipanthyl (R), the dissolution of FNB in nanomatrix increased markedly. The bioavailability study demonstrated that the C-max and AUC(0-12) of FNB in nanomatrix group were approximately 2.0- and 2.7- fold greater than that of FNB in Lipanthyl (R) group, respectively, and increased significantly compared with the reported formulation (p < 0.05). In conclusion, nanomatrix preparation according to the optimal formulation can significantly increase the dissolution and bioavailability of FNB. The CCD-RSM could quickly and accurately optimize the formulation.
What problem does this paper attempt to address?